These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37321419)

  • 1. New insights into the roles of oligodendrocytes regulation in ischemic stroke recovery.
    Huang S; Ren C; Luo Y; Ding Y; Ji X; Li S
    Neurobiol Dis; 2023 Aug; 184():106200. PubMed ID: 37321419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia.
    Mifsud G; Zammit C; Muscat R; Di Giovanni G; Valentino M
    CNS Neurosci Ther; 2014 Jul; 20(7):603-12. PubMed ID: 24703424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
    Deng YP; Sun Y; Hu L; Li ZH; Xu QM; Pei YL; Huang ZH; Yang ZG; Chen C
    Exp Neurol; 2015 Jul; 269():213-23. PubMed ID: 25862289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box-1 as an autocrine trophic factor in white matter stroke.
    Choi JY; Cui Y; Chowdhury ST; Kim BG
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4987-E4995. PubMed ID: 28584116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
    Hussien Y; Cavener DR; Popko B
    Glia; 2014 May; 62(5):680-91. PubMed ID: 24481666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS myelination and remyelination depend on fatty acid synthesis by oligodendrocytes.
    Dimas P; Montani L; Pereira JA; Moreno D; Trötzmüller M; Gerber J; Semenkovich CF; Köfeler HC; Suter U
    Elife; 2019 May; 8():. PubMed ID: 31063129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury.
    Baydyuk M; Morrison VE; Gross PS; Huang JK
    Neurochem Res; 2020 Mar; 45(3):630-642. PubMed ID: 31997102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy.
    Chen D; Huang Y; Shi Z; Li J; Zhang Y; Wang K; Smith AD; Gong Y; Gao Y
    CNS Neurosci Ther; 2020 Dec; 26(12):1219-1229. PubMed ID: 33210839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.
    Jeffries MA; Urbanek K; Torres L; Wendell SG; Rubio ME; Fyffe-Maricich SL
    J Neurosci; 2016 Aug; 36(35):9186-200. PubMed ID: 27581459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Myelin Gene Expression in the Central Nervous System Using Real-Time PCR.
    El Khoury D
    Methods Mol Biol; 2019; 2011():659-670. PubMed ID: 31273727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain.
    Gerstner B; Lee J; DeSilva TM; Jensen FE; Volpe JJ; Rosenberg PA
    J Neurosci Res; 2009 Jul; 87(9):2078-86. PubMed ID: 19224575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
    Ishii A; Furusho M; Dupree JL; Bansal R
    J Neurosci; 2016 Jun; 36(24):6471-87. PubMed ID: 27307235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
    Unal DB; Caliari SR; Lampe KJ
    Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H
    Lu W; Wen J
    Mol Neurobiol; 2023 Sep; 60(9):5493-5504. PubMed ID: 37322287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.
    Zou S; Fuss B; Fitting S; Hahn YK; Hauser KF; Knapp PE
    J Neurosci; 2015 Aug; 35(32):11384-98. PubMed ID: 26269645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
    Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
    J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG2-glia cell proliferation and differentiation by glial growth factor 2 (GGF2), a strategy to promote functional recovery after ischemic stroke.
    Li F; Liu WC; Wang Q; Sun Y; Wang H; Jin X
    Biochem Pharmacol; 2020 Jan; 171():113720. PubMed ID: 31751533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fatal alliance: Glial connexins, myelin pathology and mental disorders.
    Zlomuzica A; Plank L; Kodzaga I; Dere E
    J Psychiatr Res; 2023 Mar; 159():97-115. PubMed ID: 36701970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
    Barateiro A; Brites D; Fernandes A
    Curr Pharm Des; 2016; 22(6):656-79. PubMed ID: 26635271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aligned Brain Extracellular Matrix Promotes Differentiation and Myelination of Human-Induced Pluripotent Stem Cell-Derived Oligodendrocytes.
    Cho AN; Jin Y; Kim S; Kumar S; Shin H; Kang HC; Cho SW
    ACS Appl Mater Interfaces; 2019 May; 11(17):15344-15353. PubMed ID: 30974942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.